{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:21:12Z","timestamp":1787196072284,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["CEHEAD"],"award-info":[{"award-number":["CEHEAD"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["CEHEAD"],"award-info":[{"award-number":["CEHEAD"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["CEHEAD"],"award-info":[{"award-number":["CEHEAD"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["CEHEAD"],"award-info":[{"award-number":["CEHEAD"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Migraine is a common, polygenic disorder that is characterized by moderate to severe headache attacks. Migraine attacks are commonly treated with triptans, i.e. serotonin receptor agonists. However, triptans are effective in\u2009~\u200960% of the population, and the mechanisms of triptans are debated. Here, we aim to expose the mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks. We collected temporal multi-omics profiles on 24 migraine patients, using samples collected at a migraine attack, 2\u00a0h after treatment with a triptan, when headache-free, and after a cold-pressor test. Differential metabolomic analysis was performed to find metabolites associated with treatment. Their effect was further investigated using correlation analysis and a machine learning approach. We found three differential metabolites: cortisol, sumatriptan and glutamine. The change in sumatriptan levels correlated with a change in<jats:italic>GNAI1<\/jats:italic>and<jats:italic>VIPR2<\/jats:italic>gene expression, both known to regulate cAMP levels. Furthermore, we found fatty acid oxidation to be affected, a mechanism known to be involved in migraine but not previously found in relation to triptans. In conclusion, using an integrative approach we find evidence for a role of glutamine, cAMP regulation, and fatty acid oxidation in the molecular mechanisms of migraine and\/or the effect of triptans.<\/jats:p>","DOI":"10.1038\/s41598-023-38904-1","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T14:02:41Z","timestamp":1690812161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms"],"prefix":"10.1038","volume":"13","author":[{"given":"Lisette J. A.","family":"Kogelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Ottosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemar","family":"Stentoft-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Demharter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Tfelt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Folkmann","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"38904_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner, L. J. et al. Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 17, 954\u2013976 (2018).","journal-title":"Lancet Neurol."},{"key":"38904_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1375\/136905203770326420","volume":"6","author":"EJ Mulder","year":"2003","unstructured":"Mulder, E. J. et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 6, 422\u2013431 (2003).","journal-title":"Twin Res."},{"key":"38904_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"J Olesen","year":"2013","unstructured":"Olesen, J. et al. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33, 629\u2013808 (2013).","journal-title":"Cephalalgia"},{"issue":"9294","key":"38904_CR4","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","volume":"358","author":"MD Ferrari","year":"2001","unstructured":"Ferrari, M. D., Roon, K. I., Lipton, R. B. & Goadsby, P. J. Oral triptans (serotonin 5-HT 1B\/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358(9294), 1668\u20131675 (2001).","journal-title":"Lancet"},{"key":"38904_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0333102420905131","volume":"40","author":"PR Holland","year":"2020","unstructured":"Holland, P. R., Sureda-Gibert, P. & Vila-Pueyo, M. Rapid uptake of sumatriptan into the brain: An ongoing question of blood-brain barrier permeability. Cephalalgia 40, 327\u2013329. https:\/\/doi.org\/10.1177\/0333102420905131 (2020).","journal-title":"Cephalalgia"},{"key":"38904_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","volume":"115","author":"AH Ahn","year":"2005","unstructured":"Ahn, A. H. & Basbaum, A. I. Where do triptans act in the treatment of migraine?. Pain 115, 1 (2005).","journal-title":"Pain"},{"key":"38904_CR7","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1038\/s41598-021-87503-5","volume":"11","author":"LJA Kogelman","year":"2021","unstructured":"Kogelman, L. J. A. et al. Changes in the gene expression profile during spontaneous migraine attacks. Sci. Rep. 11, 8294 (2021).","journal-title":"Sci. Rep."},{"key":"38904_CR8","doi-asserted-by":"publisher","DOI":"10.21203\/RS.3.RS-1305269\/V1","author":"LJA Kogelman","year":"2022","unstructured":"Kogelman, L. J. A. et al. Multi-omics to predict changes during cold pressor test. BMC Genom. https:\/\/doi.org\/10.21203\/RS.3.RS-1305269\/V1 (2022).","journal-title":"BMC Genom."},{"key":"38904_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nbt.3597","volume":"34","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat. Biotechnol. 34, 828\u2013837 (2016).","journal-title":"Nat. Biotechnol."},{"key":"38904_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41592-020-0933-6","volume":"17","author":"LF Nothias","year":"2020","unstructured":"Nothias, L. F. et al. Feature-based molecular networking in the GNPS analysis environment. Nat. Methods. 17, 905\u2013908 (2020).","journal-title":"Nat. Methods."},{"key":"38904_CR11","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.1073\/pnas.1608041113","volume":"113","author":"JJJ Van Der Hooft","year":"2016","unstructured":"Van Der Hooft, J. J. J., Wandy, J., Barrett, M. P., Burgess, K. E. V. & Rogers, S. Topic modeling for untargeted substructure exploration in metabolomics. Proc. Natl. Acad. Sci. U S A. 113, 13738\u201313743 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"38904_CR12","doi-asserted-by":"publisher","first-page":"e1006089","DOI":"10.1371\/journal.pcbi.1006089","volume":"14","author":"RR da Silva","year":"2018","unstructured":"da Silva, R. R. et al. Propagating annotations of molecular networks using in silico fragmentation. PLOS Comput. Biol. 14, e1006089 (2018).","journal-title":"PLOS Comput. Biol."},{"key":"38904_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/metabo9070144","volume":"9","author":"M Ernst","year":"2019","unstructured":"Ernst, M. et al. MolNetEnhancer: Enhanced molecular networks by integrating metabolome mining and annotation tools. Metabolites 9, 144 (2019).","journal-title":"Metabolites"},{"key":"38904_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41592-019-0344-8","volume":"16","author":"K D\u00fchrkop","year":"2019","unstructured":"D\u00fchrkop, K. et al. SIRIUS 4: A rapid tool for turning tandem mass spectra into metabolite structure information. Nat. Methods. 16, 299\u2013302 (2019).","journal-title":"Nat. Methods."},{"issue":"4","key":"38904_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41587-020-0740-8","volume":"39","author":"K D\u00fchrkop","year":"2020","unstructured":"D\u00fchrkop, K. et al. Systematic classification of unknown metabolites using high-resolution fragmentation mass spectra. Nat. Biotechnol. 39(4), 462\u2013471 (2020).","journal-title":"Nat. Biotechnol."},{"key":"38904_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis: Chemical analysis working group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211\u2013221 (2007).","journal-title":"Metabolomics"},{"key":"38904_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"38904_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"M Love","year":"2014","unstructured":"Love, M., Anders, S. & Huber, W. Differential analysis of count data\u2013the DESeq2 package. Genome Biol. 15, 10\u20131186 (2014).","journal-title":"Genome Biol."},{"key":"38904_CR19","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/bioinformatics\/btac405","volume":"38","author":"NJ Christensen","year":"2022","unstructured":"Christensen, N. J. et al. Identifying interactions in omics data for clinical biomarker discovery using symbolic regression. Bioinformatics 38, 3749\u20133758 (2022).","journal-title":"Bioinformatics"},{"key":"38904_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01285-9","volume":"22","author":"T Acz\u00e9l","year":"2021","unstructured":"Acz\u00e9l, T. et al. Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis. J. Headache. Pain. 22, 1\u201318 (2021).","journal-title":"J. Headache. Pain."},{"key":"38904_CR21","first-page":"95","volume":"29","author":"G Lippi","year":"2017","unstructured":"Lippi, G. & Mattiuzzi, C. Cortisol and migraine: A systematic literature review. Agri 29, 95\u201399 (2017).","journal-title":"Agri"},{"key":"38904_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j1468-2982200200310.x","volume":"22","author":"LH Lassen","year":"2016","unstructured":"Lassen, L. H. et al. Cgrp may play a causative role in migraine. Cephalalgia 22, 54\u201361. https:\/\/doi.org\/10.1046\/j1468-2982200200310.x (2016).","journal-title":"Cephalalgia"},{"key":"38904_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nurt.2010.02.003","volume":"7","author":"HW Schytz","year":"2010","unstructured":"Schytz, H. W., Olesen, J. & Ashina, M. The PACAP receptor: A novel target for migraine treatment. Neurotherapeutics 7, 191\u2013196 (2010).","journal-title":"Neurotherapeutics"},{"key":"38904_CR24","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo, S., Olesen, J. & Ashina, M. Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain 137, 2951\u20132959 (2014).","journal-title":"Brain"},{"key":"38904_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell, F. A., King, R., Smillie, S. J., Kodji, X. & Brain, S. D. Calcitonin gene-related peptide: Physiology and pathophysiology. Physiol. Rev. 94, 1099 (2014).","journal-title":"Physiol. Rev."},{"key":"38904_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/03331024211017882","volume":"41","author":"T Benbow","year":"2021","unstructured":"Benbow, T. & Cairns, B. E. Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?. Cephalalgia 41, 1249 (2021).","journal-title":"Cephalalgia"},{"key":"38904_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.59566\/IJBS.2013.9001","volume":"9","author":"CF Gasparini","year":"2013","unstructured":"Gasparini, C. F. & Griffiths, L. R. the biology of the glutamatergic system and potential role in migraine. Int. J. Biomed. Sci. 9, 1 (2013).","journal-title":"Int. J. Biomed. Sci."},{"key":"38904_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1526-4610.2007.00812.x","volume":"47","author":"DSDS Vieira","year":"2007","unstructured":"Vieira, D. S. D. S. et al. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Headache 47, 842\u2013847 (2007).","journal-title":"Headache"},{"key":"38904_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1744-8069-4-54","volume":"4","author":"HJ Jeong","year":"2008","unstructured":"Jeong, H. J., Chenu, D., Johnson, E. E., Connor, M. & Vaughan, C. W. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol. Pain. 4, 54 (2008).","journal-title":"Mol. Pain."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38904-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T05:00:54Z","timestamp":1702875654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38904-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38904-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.S\u2013H and S.D. are employed at Abzu, developers of the QLattice. The QLattice is freely available for non-commercial use. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12395"}}